Stroke Trial, Recruiting NCT05878223 Sponsor: National Taiwan University Hospital Hsin-Chu Branch Condition: Stroke
Back to Stroke

Stroke Trial, Recruiting

NCT05878223
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have had a cerebral stroke and are over 20 years old
  • People who have muscle stiffness (spasticity) in the foot/ankle muscles that point the foot downward, rated above 1 on a standard medical scale called the Modified Ashworth Scale
  • People whose basic body signs (such as heart rate and blood pressure) are stable

Who may not be able to join:

  • People who have had more than one stroke, a brain injury from an accident, a brain tumour, or any other brain-related condition
  • People who have another condition affecting the brain or spinal cord (such as spinal cord injury or Parkinson's disease), or a bone, muscle, or joint problem that could affect how muscle stiffness is measured
  • People who have a malignant (cancerous) tumour, a blood clotting disorder, an active infection, or who have a pacemaker, as these conditions may make the shock wave treatment used in this trial unsuitable (confirm with trial site)
  • People who have received shock wave therapy or Botulinum toxin (commonly known as Botox) injections for foot/ankle muscle stiffness within the past 3 months
  • People who are unable to complete the treatment sessions or assessments due to difficulties with thinking, understanding, or communication

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 15 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Meng Ting Lin, MD, The Department of Physical Medicine and Rehabilitation, National Taiwan University Hospital

Phone: +8863-5326151

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
National Taiwan University Hospital Hsin-Chu Branch
Registry
ClinicalTrials.gov
Start date
1 January 2022
Est. completion
30 July 2024

Where this trial is recruiting

🇹🇼 Taiwan

Primary endpoints

Change in Modified Ashworth Scale (MAS)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov